Skip to main content

Advertisement

Log in

HIV in the CNS: Pathogenic relationships to systemic HIV disease and other CNS diseases

  • Review
  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

Research on the pathogenesis of the human immunodeficiency virus (HIV) infection of the central nervous system (CNS) has reached a pivotal stage. While the incidence of HIV dementia appears to be declining, the prevalence of milder, yet debilitating, neuropsychological impairments may rise as individuals infected with HIV live longer. There are also concerns about CNS reservoirs of latently infected cells. Building upon progress in understanding HIV neuropathogenesis, the time is ideal to expand research on the interrelationships between the CNS and systemic HIV disease, and extend the boundaries of this research to the neuropathogenic similarities between HIV and other CNS inflammatory diseases. Neuropathogenic insights gained from these pursuits can spawn new treatment strategies for HIV/CNS disease as well as potentially other diseases of the nervous system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Albert SM, Marder K, Dooneief G, Bell K, Sano M, Todak G, Stern Y (1995). Neuropsychologic impairment in early HIV infection. A risk factor for work disability. Arch Neurol 52: 525–530.

    CAS  PubMed  Google Scholar 

  • Asensio V, Campbell I (1999). Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci 22: 504–512.

    Article  CAS  PubMed  Google Scholar 

  • Aweeka F, Jayewardene A, Staprans S, Belibas SE, Kearney B, Lizak P, Novakovic-Agopian T, Price RW (1999). Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1 infected patients with and without AIDS dementia complex. J Acquir Immune Defic Syndr Hum Retrovirol 20: 39–43.

    CAS  PubMed  Google Scholar 

  • Banks WA (1999). Physiology and pathology of the blood-brain barrier: Implications for microbial pathogenesis, drug delivery and neurodegenerative disorders. J NeuroVirol 5: 538–555.

    Article  CAS  PubMed  Google Scholar 

  • Bell JE, Busuttil A, Ironside JE, Rebus S, Donaldson YK, Simmonds P, Peutherer JF (1993). Human immunodeficiency virus and the brain: Investigations of virus load and neuropathologic changes in pre-AIDS subjects. J Infect Dis 168: 818–824.

    CAS  PubMed  Google Scholar 

  • Benveniste E (1998). Cytokine actions in the central nervous system. Cytokine Growth Factor Rev 9: 259–275.

    Article  CAS  PubMed  Google Scholar 

  • Bo L, Dawson T, Wesselingh S, Mork S, Choi S, Kong PA, Hanley D, Trapp BD (1994). Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36: 778–786.

    Article  CAS  PubMed  Google Scholar 

  • Brosnan C, Raine C (1996). Mechanisms of immune injury in multiple sclerosis. Brain Pathol 6: 243–257.

    Article  CAS  PubMed  Google Scholar 

  • Budka H (1991). Neuropathology of human immunodeficiency virus infection. Brain Pathol 1: 163–175.

    Article  CAS  PubMed  Google Scholar 

  • Center for Disease Control (CDC) (1999). New data show continued decline in AIDS deaths. http://www.cdc.gov/od/oc/media/pressrel/r990831.htm)

  • Choi DW (1988). Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623–634.

    Article  CAS  PubMed  Google Scholar 

  • Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hemankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Silciano RF (1997). Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387: 183–188.

    Article  CAS  PubMed  Google Scholar 

  • Chun TW, Davey RT, Ostrowski M, Justement JS, Engel D, Mullins JI, Fauci AS (2000). Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat Med 6: 757–761.

    Article  CAS  PubMed  Google Scholar 

  • Chun TW, Engel D, Mizell SB, Hallahan CW, Fischette M, Park S, Davey RT Jr, Dybul M, Kovacs JA, Metcalf JA, Mican JM, Berry MM, Corey L, Lane HC, Fauci AS (1999). Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1 infected patients receiving highly active anti-retroviral therapy. Nat Med 5: 651–655.

    Article  CAS  PubMed  Google Scholar 

  • Chun TW, Fauci AS (1999). Latent reservoirs of HIV: Obstacles to the eradication of virus. Proc Natl Acad Sci USA 96: 10958–10961.

    Article  CAS  PubMed  Google Scholar 

  • Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, Vicenzi E, Transidico P, Vagani A, Sozzani S, Mantovani A, Lazzarin A, Poli G (1998). Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlated with HIV-1 encephalitis and local viral replication. AIDS 12: 1327–1332.

    Article  CAS  PubMed  Google Scholar 

  • Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998). Induction of monocyte chemoattractant protein-1 in HIV-1 Tatstimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 95: 3117–3121.

    Article  CAS  PubMed  Google Scholar 

  • Conlon P, Oksenberg JR, Zhang J, Steinman L (1999). The immunobiology of multiple sclerosis: an autoimmune disease of the central nervous system. Neurobiol Dis 6: 149–166.

    Article  CAS  PubMed  Google Scholar 

  • Cotter RL, Burke WJ, Thomas VS, Potter JF, Zheng J, Gendclman HE (1999). Insights into the neurodegenerative process of Alzheimer’s disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity. J Leukoc Biol 65: 416–427.

    CAS  PubMed  Google Scholar 

  • Cross AH, Cannella B, Brosnan CF, Raine CS (1990). Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest 63: 162–170.

    CAS  PubMed  Google Scholar 

  • Cross AH, O’Mara T, Raine CS (1993). Chronic localization of myelin-reactive cells in the lesions of relapsing EAE: implications for the study of multiple sclerosis. Neurology 43: 1028–1033.

    CAS  PubMed  Google Scholar 

  • Dallasta LM, Pisarove LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL (1999). Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 155: 1915–1927.

    CAS  PubMed  Google Scholar 

  • Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, Young SA, Mills RG, Wachsman W, Wiley CA (1992). Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42: 1736–1739.

    CAS  PubMed  Google Scholar 

  • Dhawan S, Puri RK, Kumar A, Duplan H, Mason JM, Aggrawal BB (1997). Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 90: 1535–1544.

    CAS  PubMed  Google Scholar 

  • Dickson DW, Lee SC, Mattiace LA, Yen SC, Brosnan C (1993). Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer’s disease. Glia 7: 75–83.

    Article  CAS  PubMed  Google Scholar 

  • Donaldson YK, Bell JE, Ironside JW, Brettle RP, Roberston JR, Busuttil A, Simmonds P (1994). Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet 343: 383–385.

    Article  CAS  PubMed  Google Scholar 

  • Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ (1999). Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13: 1249–1253.

    Article  CAS  PubMed  Google Scholar 

  • Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR, Grant I (1997). Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol 54: 416–424.

    CAS  PubMed  Google Scholar 

  • Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson T, Abramson I, Grant I, McCutchan JA (2000). Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 54: 927–936.

    CAS  PubMed  Google Scholar 

  • Engelborghs S, De Brabander M, De Cree J, D’Hooge R, Geerts H, Verhaegen H, De Deyn PP (1999). Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type. Neurochem Int 34: 523–530.

    Article  CAS  PubMed  Google Scholar 

  • Enting RH, Hoetelmans RM, Lange JM, Burger DM, Beijnen JH, Portegies P (1998). Antiretroviral drugs and the central nervous system. AIDS 12: 1941–1955.

    Article  CAS  PubMed  Google Scholar 

  • Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M, Masliah E (1999). Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol 9: 209–217.

    Article  CAS  PubMed  Google Scholar 

  • Ferrando S, van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J (1998). Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS 12: F65-F70.

    Article  CAS  PubMed  Google Scholar 

  • Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewiccz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, Siliciano RF (1999). Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5: 512–517.

    Article  CAS  PubMed  Google Scholar 

  • Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF (1997). Identification of a reservoir for HIV-1 in patients on highly active antiretroviraltherapy. Science 278: 1295–1300.

    Article  CAS  PubMed  Google Scholar 

  • Flexner C (1998). HIV-protease inhibitors. N Engl J Med 338: 1281–1292.

    Article  CAS  PubMed  Google Scholar 

  • Frankenberger M, Sternsdorf T, Pechumer H, Pforte A, Ziegler-Heitbrock HW (1996). Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 87: 373–377.

    CAS  PubMed  Google Scholar 

  • Gartner S (2000). HIV infection and dementia. Science 287: 602–604.

    Article  CAS  PubMed  Google Scholar 

  • Gitter BD, Cox LM, Rydel RE, May PC (1995). Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. Proc Natl Acad Sci USA 92: 10738–10741.

    Article  CAS  PubMed  Google Scholar 

  • Giulian D, Vaca K, Noonan CA (1990). Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250: 1593–1596.

    Article  CAS  PubMed  Google Scholar 

  • Glabinski AR, Ransohoff RM (1999). Sentries at the gate: chemokines and the blood-brain barrier. J NeuroVirol 5: 623–634.

    Article  CAS  PubMed  Google Scholar 

  • Glass JD, Fedor H, Wesslingh SL, McArthur JC (1995). Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755–762.

    Article  CAS  PubMed  Google Scholar 

  • Gonzalez-Scarano F, Baltuch G (1999). Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22: 219–240.

    Article  CAS  PubMed  Google Scholar 

  • Grant I, Heaton RK, Atkinson JH (1995). Neurocognitive disorders in HIV-1 infection. HNRC Group. HIV Neurobehavioral Research Center. Curr Top Microbiol Immunol 202: 11–32.

    CAS  PubMed  Google Scholar 

  • Griffin DE (1998). HIV infection of the brain: viruses, cytokines, and immune regulatory factors associated with dementia. In: The neurology of AIDS. Gendelman HE, Lipton SA, Epstein L, Swindells, (eds). New York: Chapman and Hall, pp 73–85.

    Google Scholar 

  • Heaton RK, Marcotte TD, White DA, Ross D, Meredith K, Taylor MJ, Kaplan R, Grant I (1996). Nature and vocational significance of neuropsychiatric impairment associated with HIV infection. Clin Neuropsychol 10: 1–14.

    Article  Google Scholar 

  • Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, Godfrey HP, Kirson DA, Grant I (1994). Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med 56: 8–17.

    CAS  PubMed  Google Scholar 

  • Hesselgesser J, Horuk R (1999). Chemokine and chemokine receptor expression in the central nervous system. J Neuro Virol 5: 13–26.

    CAS  Google Scholar 

  • Heyes MP, Jordan EK, Lee K, Saito K, Frank JA, Snoy PJ, Markey SP, Gravall M (1992). Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebral spinal fluid quinolinic acid and kynurenic acid. Brain Res 570: 237–250.

    Article  CAS  PubMed  Google Scholar 

  • Hickey WF (1999a). Leukocyte traffic in the central nervous system: the participants and their roles. Semin Immunol 98: 125–137.

    Article  Google Scholar 

  • Hickey WF (1999b). The pathology of multiple sclerosis: a historical perspective. J Neuroimmunol 98: 37–44.

    Article  CAS  PubMed  Google Scholar 

  • Hickey WF, Hsu BL, Kimura H (1991). T-lymphocyte entry into the central nervous system. J Neurosci Res 51: 254–260.

    Article  Google Scholar 

  • Hickey WF, Vass K, Lassmann H (1992). Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J Neuropathol Exp Neurol 51: 246–256.

    Article  CAS  PubMed  Google Scholar 

  • Horuk R, Martin AW, Wang Z, Schweitzer L, Gerassimides A, Guo H, Lu Z, Hesselgesser J, Perez HD, Kim J, Parker J, Hadley TJ, Peiper SC (1997). Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158: 2882–2890.

    CAS  PubMed  Google Scholar 

  • Hughes ES, Bell JE, Simmonds P (1997). Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes. J Virol 71: 1272–1280.

    CAS  PubMed  Google Scholar 

  • Hurtrel B, Chakrabarti L, Hurtrel M, Maire MA, Dormont D, Montagnier L (1991). Early SIV encephalopathy. J Med Primatol 20: 159–166.

    CAS  PubMed  Google Scholar 

  • Imami N, Antonopoulos C, Hardy GA, Gazzard B, Gotch FM (1999). Assessment of type 1 and type 2 cytokinesin HIV type 1-infected individuals: impact of highly active antiretroviral therapy. AIDS Res Hum Retroviruses 15: 1499–1508.

    Article  CAS  PubMed  Google Scholar 

  • Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD (1995). An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-medicatedautoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155: 5003–5010.

    CAS  PubMed  Google Scholar 

  • Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE (1998). Betachemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 44: 831–835.

    Article  CAS  PubMed  Google Scholar 

  • Kepler TB, Perelson AS (1998). Drug concentration heterogeneity facilitates the evolution of drug resistance. Proc Natl Acad Sci USA 95: 11514–11519.

    Article  CAS  PubMed  Google Scholar 

  • Klegeris A, McGeer PL (2000). Interaction of various intra-cellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells. J Leukoc Biol 67: 127–133.

    CAS  PubMed  Google Scholar 

  • Kolb SA, Sporer B, Lahrtz F, Koedel U, Pfister HW, Fontana A (1999). Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1 infected individuals as interferon-gamma inducible protein 10. J Neuroimmunol 93: 172–181.

    Article  CAS  PubMed  Google Scholar 

  • Kolson DL, Lavi E, Gonzalez-Scarano F (1998). The effects of human immunodeficiency virus in the central nervous system. Adv Virus Res 50: 1–47.

    Article  CAS  PubMed  Google Scholar 

  • Kopec KK, Carroll RT (1998). Alzheimer’s beta-amyloid peptide 1–42 induces a phagocytic response in murine microglia. J Neurochem 71: 2123–2131.

    Article  CAS  PubMed  Google Scholar 

  • Korber BT, Kunstman KJ, Patterson BK, Furtado M, McEvilly MM, Levy R, Wolinsky SM (1994). Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type-1 infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 68: 7467–7481.

    CAS  PubMed  Google Scholar 

  • Kusdra L, Rempel H, Yaffe K, Pulliam L (2000). Elevation of CD69+ monocyte/macrophages in patients with Alzheimer’s disease. Immunobiol 202: 26–33.

    CAS  Google Scholar 

  • Lackner AA, Smith MO, Munn RJ, Martfeld DJ, Gardner MB, Marx PA, Dandekar S (1991). Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys. Am J Pathol 139: 609–621.

    CAS  PubMed  Google Scholar 

  • Lanzrein AS, Johnston CM, Perry VH, Jobst KA, King EM, Smith AD (1998). Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1 beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha 1-antichymotrypsin. Alzheimer Dis Assoc Disord 12: 215–227.

    Article  CAS  PubMed  Google Scholar 

  • Lassmann H (1999). The pathology of multiple sclerosis and its evolution. Philos Trans R Soc Lond B Biol Sci 354: 1635–1640.

    Article  CAS  PubMed  Google Scholar 

  • Lassman H, Brunner C, Bradl M, Linington C (1988). Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol (Berl) 75: 566–576.

    Article  Google Scholar 

  • Lassmann H, Schmied M, Vass K, Hickey WF (1993). Bone marrow derived elements and resident microglia in brain inflammation. Glia 7: 19–24.

    Article  CAS  PubMed  Google Scholar 

  • Lipton SA (1998). Neuronal injury associated with HIV-1: approaches to treatment. Annu Rev Pharmacol Toxicol 38: 159–177.

    Article  CAS  PubMed  Google Scholar 

  • Lipton SA, Rosenberg PA (1994). Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330: 613–622.

    Article  CAS  PubMed  Google Scholar 

  • Liu Y, Tang XP, McArthur JC, Scott J, Gartner S (2000). Analysis of human immunodeficiency virus type 1 gp 160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J NeuroVirol 6 Suppl 1: S70–81.

    CAS  PubMed  Google Scholar 

  • Luster AD (1998). Chemokines—chemotactic cytokines that mediate inflammation. N Engl J Med 338: 436–445.

    Article  CAS  PubMed  Google Scholar 

  • Maeda K, Nakai M, Maeda S, Kawamata T, Yamaguchi T, Tanaka C (1997). Possible different mechanisms between amyloid-beta (25–35)- and substance P-induced chemotaxis of murine microglia. Gerontology 43 Suppl 1: 11–15.

    Article  CAS  PubMed  Google Scholar 

  • Martin C, Sonnerborg A, Svensson JO, Stahle L (1999). Indinavir-based treatment of HIV-1 infected patients: efficacy in the central nervous system. AIDS 13: 1227–1232.

    Article  CAS  PubMed  Google Scholar 

  • Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, Portera-Cailliau C (1998). Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res Bull 46: 281–309.

    Article  CAS  PubMed  Google Scholar 

  • Masliah E, DeTeresa RM, Mallory ME, Hansen LA (2000). Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 14: 69–74.

    Article  CAS  PubMed  Google Scholar 

  • Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I (1997). Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 42: 963–972.

    Article  CAS  PubMed  Google Scholar 

  • McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NMH, McArthur JH, Selnes OA, Jacobson LP, Visscher BR, Concha M, Saah A (1993). Dementia in AIDS patients: incidence and risk factors. Neurology 43: 2245–2252.

    CAS  PubMed  Google Scholar 

  • McDonald JW, Althomsons SP, Hyre KL, Choi DW, Goldberg MP (1998). Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 4: 291–297.

    Article  CAS  PubMed  Google Scholar 

  • McDonald WI, Ron MA (1999). Multiple sclerosis: the disease and its manifestations. Philos Trans R Soc Lond B Biol Sci 354: 1615–1622.

    Article  CAS  PubMed  Google Scholar 

  • McGeer PL, McGeer EG (1999). Inflammation of the brain in Alzheimer’s disease: implications for therapy. J Leukoc Biol 65: 409–415.

    CAS  PubMed  Google Scholar 

  • Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ (1998). Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 95: 14500–14505.

    Article  CAS  PubMed  Google Scholar 

  • Miller DW (1999). Immunobiology of the blood-brain barrier. J NeuroVirol 5: 570–578.

    Article  CAS  PubMed  Google Scholar 

  • Montaner JS, Reiss P, Cooper D, Vella S, Harris M, Conway B, Wainberg MA, Smith D, Robinson P, Hall D, Myers M, Lange JM (1998). A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS trial. Italy, The Netherlands, Canada, and Australia Study. JAMA 279: 930–937.

    Article  CAS  PubMed  Google Scholar 

  • Morris A, Marsden M, Halcrow K, Hughes ES, Brettle RP, Bell JE, Simmonds P (1999). Mosaic structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations. J Virol 73: 8720–8731.

    CAS  PubMed  Google Scholar 

  • Mrak RE, Griffin WS (1997). The role of chronic self-propagating glial responses in neurodegeneration: implications for long-lived survivors of human immunodeficiency virus. J NeuroVirol 3: 241–246.

    Article  CAS  PubMed  Google Scholar 

  • Navia BA, Cho ES, Petito CK, Price RW (1986b). The AIDS dementia complex: II. Neuropathology. Ann Neurol 19: 525–535.

    Article  CAS  PubMed  Google Scholar 

  • Navia BA, Jordan BD, Price RW (1986a). The AIDS dementia complex: I. Clinical features. Ann Neurol 19: 517–524.

    Article  CAS  PubMed  Google Scholar 

  • Nicoll JAR, Mrak RE, Graham DI, Stewart J, Wilcock G, MacGowan S, Esiri MM, Murray LS, Dewar D, Love S, Moss T, Griffin WSF (2000). Association of interleukin-1 gene polymorphisms with Alzheimer’s disease. Ann Neurol 47: 365–368.

    Article  CAS  PubMed  Google Scholar 

  • Nuovo GJ, Alfieri ML (1996). AIDS dementia is associated with massive, active HIV-1 infection and concomitant expression of several cytokines. Mol Med 2: 358–366.

    Article  CAS  PubMed  Google Scholar 

  • Ozawa K, Suchanek G, Breitschopf H, Bruck W, Budka H, Jellinger K, Lassman H (1994). Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117 (Pt 6): 1311–1322.

    Article  PubMed  Google Scholar 

  • Pang S, Vinters HV, Akashi T, O’Brien WA, Chen IS (1991). HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease. J Acquir Immun Defic Syndr 4: 1082–1092.

    CAS  Google Scholar 

  • Paresce DM, Chung H, Maxfield FR (1997). Slow degradation of aggregates of the Alzheimer’s disease amyloid beta-protein by microglial cells. J Biol Chem 272: 29390–29397.

    Article  CAS  PubMed  Google Scholar 

  • Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M (1997). A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 158: 3499–3510.

    CAS  PubMed  Google Scholar 

  • Petito CK, Cash KS (1992). Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 32: 658–666.

    Article  CAS  PubMed  Google Scholar 

  • Petito CK, Chen H, Mastri AR, Torres-Munoz J, Roberts B, Wood C (1999). HIV infection of choroid plexus in AIDS and asymptomatic HIV-infected patients suggests that the choroid plexus may be a reservoir of productive infection. J NeuroVirol 5: 670–677.

    Article  CAS  PubMed  Google Scholar 

  • Piani D, Frei K, Do KQ, Cuenod M, Fontana A (1991). Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett 133: 159–162.

    Article  CAS  PubMed  Google Scholar 

  • Powderly WG (2000). Current approaches to treatment for HIV-1 infection. J NeuroVirol 6 Suppl 1: S8-S14.

    CAS  PubMed  Google Scholar 

  • Price RW, Brew B, Sidtis J, Rosenblum M, Scheck A, Cleary P (1988). The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239: 586–592.

    Article  CAS  PubMed  Google Scholar 

  • Price RW, Staprans S (1997). Measuring the “viral load” in cerebrospinal fluid in human immunodeficiency virus infection: window into brain infection? Ann Neurol 42: 675–678.

    Article  CAS  PubMed  Google Scholar 

  • Pulliam gnL, Clarke JA, McGrath MS, Moore D, McGuire D.( ) Monokine products as predictors of AIDS dementia. AIDS 10: 1495–1500.

  • Pulliam LR, Gascon M, Stubblebine D, McGuire D, McGrath MS (1977). Unique monocyte subset in patients with AIDS dementia. Lancet 349: 692–695.

    Article  Google Scholar 

  • Pulliam L, Herndier BG, Tang NM, McGrath MS (1991). Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest 87: 503–512.

    Article  CAS  PubMed  Google Scholar 

  • Pulliam L, Zhou M, Stubblebine M, Bitler CM (1998). Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor. J Neurosci Res 15: 530–538.

    Article  Google Scholar 

  • Ransohoff RM (1999). Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J Neuroimmunol 98: 57–68.

    Article  CAS  PubMed  Google Scholar 

  • Rausch DM, Heyes MP, Murray EA, Lendvay J, Sharer LR, Ward JM, Rehm S, Weihe E, Eiden LE (1994). Cytopathologic and neurochemical correlates of progression to motor/cognitive impairment in SIV-infected rhesus monkeys. J Neuropathol Exp Neurol 53: 165–175.

    Article  CAS  PubMed  Google Scholar 

  • Rausch DM, Stover ES (2000). Neuroscience research in AIDS. Prog Neuro-Psychopharmacol in press.

  • Richman DD (1996). HIV therapeutics. Science 272: 1886–1888.

    Article  CAS  PubMed  Google Scholar 

  • Rothman SM, Olney JW (1995). Excitotoxicity and the NMDA receptor—still lethal after eight years. Trends Neurosci 18: 57–58.

    Article  CAS  PubMed  Google Scholar 

  • Sacktor NC, Lyles RH, McFarlane G (1999b). HIV-1 related neurological disease incidence changes in the era of highly active antiretroviral therapy. Neurology 52: A252-A253.

    Google Scholar 

  • Sacktor NC, Lyles RH, Skolasky RL, Anderson DE, McArthur JC, McFarlane G, Selnes OA, Becker JT, Cohen B, Wesch J, Miller EN (1999a). Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 52: 1640–1647.

    CAS  PubMed  Google Scholar 

  • Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC (2000). Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J NeuroVirol 6: 84–88.

    Article  CAS  PubMed  Google Scholar 

  • Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA, Achim CL (1998). Chemokines and receptors in HIV encephalitis. AIDS 12: 1021–1026.

    Article  CAS  PubMed  Google Scholar 

  • Sasseville VG, Smith MM, Mackay CR, Pauley DR, Mansfield KG, Ringler DJ, Lackner AA (1996). Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am J Pathol 149: 1459–1467.

    CAS  PubMed  Google Scholar 

  • Schmidtmayerova H, Nottet HS, Nuovo G, Raabe T, Flanagan CR, Dubrovsky L, Gendelman HE, Cerami A, Bukrinsky M, Sherry B (1996). Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci USA 93: 700–704.

    Article  CAS  PubMed  Google Scholar 

  • Schrager LK, D’Souza MP (1998). Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. JAMA 280: 67–71.

    Article  CAS  PubMed  Google Scholar 

  • Scolding N (1999). Therapeutic strategies in multiple sclerosis. II. Long-term repair. Philos Trans R Soc Lond R Riol Sci 354: 1711–1720.

    Article  CAS  Google Scholar 

  • Sei S, Saito K, Stewart SK, Crowley JS, Brouwers P, Kleiner DE, Katz DA, Pizzo PA, Heyes MP (1995). Increased human immunodeficiency virus (HIV) type 1 DNA content and quinolinic acid concentration in brain tissues from patients with HIV encephalopathy. J Infect Dis 172: 638–647.

    CAS  PubMed  Google Scholar 

  • Selkoe DJ (1999). Translating cell biology into therapeutic advances in Alzheimer’s disease. Nature 399 (6738 Suppl): A23-A31.

    CAS  PubMed  Google Scholar 

  • Selmaj KW, Raine CS (1988). Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339–346.

    Article  CAS  PubMed  Google Scholar 

  • Shapshak P, Segal DM, Crandall KA, Fujimura RK, Zhang BT, Xin KQ, Okuda K, Petito CK, Eisdorfer C, Goodkin K (1999). Independent evolution of HIV type 1 in different brain regions. AIDS Res Hum Retroviruses 15: 811–820.

    Article  CAS  PubMed  Google Scholar 

  • Sharer LR, Michaels J, Murphey-Corb M, Hu FS, Kueler DJ, Martin LN, Baskin GB (1991). Serial pathogenesis study of SIV brain infection. J Med Primatol 20: 211–217.

    CAS  PubMed  Google Scholar 

  • Sharief MK, Hentges R (1991). Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325: 467–472.

    Article  CAS  PubMed  Google Scholar 

  • Sinclair E, Gray F, Ciardi A, Scaravilli F (1994). Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J Neuropathol Exp Neurol 53: 43–50.

    Article  CAS  PubMed  Google Scholar 

  • Smith KJ, McDonald WI (1999). The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond R Riol Sci 354: 1649–1673.

    Article  CAS  Google Scholar 

  • Sorenson TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folchik VA, Quin S, Rottman J, Sellebjerg F, Stricter RM, Frederickson JL, Ransohoff RM (1999). Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103: 807–815.

    Article  Google Scholar 

  • Stout JC, Ellis RJ, Jernigan TL, Archibald SL, Abramson I, Wolfson T, McCutchan JA, Wallace MR, Atkinson JH, Grant I (1998). Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol 55: 161–168.

    Article  CAS  PubMed  Google Scholar 

  • Stover JF, Pleines UE, Morganti-Kossman MC, Kossmann T, Lowitzsch K, Kempski OS (1997). Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur J Clin Invest 27: 1038–1043.

    Article  CAS  PubMed  Google Scholar 

  • Tozzi V, Balestra P, Galani S, Narciso P, Sebastiani G, D’Amato C, Affticano C, Pigorini F, Pau FM, De Felici A, Benedetto A (1999). Positive and sustained effects of highly active antiretroviral therapy on HIV-1 associated neurocognitive impairment. AIDS 13: 1889–1997.

    Article  CAS  PubMed  Google Scholar 

  • Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998). Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338: 278–285.

    Article  CAS  PubMed  Google Scholar 

  • van’t Wout AB, Ran LJ, Kuiken CL, Kookstra NA, Pals ST, Schuitemaker H (1998). Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. J Virol 72: 488–496.

    Google Scholar 

  • Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, Farber JM, Griffin JW, Griffin DE (1993). Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 33: 576–582.

    Article  CAS  PubMed  Google Scholar 

  • Westmoreland SV, Halpern E, Lackner AA (1998). Simian immunodeficiency virus encephalitis in rhesus macaques is associated with rapid disease progression. J NeuroVirol 4: 260–268.

    Article  CAS  PubMed  Google Scholar 

  • Wiley CA, Achim CL, Christopherson C, Kidane Y, Kwok S, Masliah E, Mellors J, Radhakrishnan L, Wang G, Soontornniyomkij V (1999). HIV mediates a productive infection of the brain. AIDS 13: 2055–2059.

    Article  CAS  PubMed  Google Scholar 

  • Wiley CA, Soontornniyomkij V, Radhakrishnan L, Masliah E, Mellors J, Hermann SA, Dailey P, Achim CL (1998). Distribution of brain HIV load in AIDS. Brain Pathol 8: 277–284.

    Article  CAS  PubMed  Google Scholar 

  • Williams KC, Ulvestad E, Hickey WF (1994). Immunology of multiple sclerosis. Clin Neurosci 2: 229–245.

    CAS  PubMed  Google Scholar 

  • Wilt SG, Milward E, Zhou JM, Nagasato K, Patton H, Rusten R, Griffen DE, O’Connor M, Dubois-Dalcq M (1995). In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy. Ann Neurol 37: 381–394.

    Article  CAS  PubMed  Google Scholar 

  • Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD (1997). Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278: 1291–1295.

    Article  CAS  PubMed  Google Scholar 

  • Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJ, Richman DD (1997). In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J Virol 71: 2059–2071.

    CAS  PubMed  Google Scholar 

  • Xia M, Qin S, McNamara M, Mackay C, Hyman BT (1997). Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer’s disease. Am J Pathol 150: 1267–1274.

    CAS  PubMed  Google Scholar 

  • Xia MQ, Hyman BT (1999). Chemokines/chemokine receptors in the central nervous system and Alzheimer’s disease. J NeuroVirol 5: 32–41.

    Article  CAS  PubMed  Google Scholar 

  • Xiong H, Zeng YC, Lewis T, Zheng J, Persidsky Y, Gendelman HE (2000). HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1 associated dementia. J NeuroVirol 6 Suppl 1: S14-S23.

    CAS  PubMed  Google Scholar 

  • Yankner BA, Duffy LK, Kirschner DA (1990). Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250: 279–282.

    Article  CAS  PubMed  Google Scholar 

  • Yeh MW, Kaul M, Zheng J, Nottet HS, Thylin M, Gendelman HE, Lipton SA (2000). Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of 1-cysteine. J Immunol 164: 4265–4270.

    CAS  PubMed  Google Scholar 

  • Zheng J, Gendelman HE (1997). The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr Opin Neurol 10: 319–325.

    Article  CAS  PubMed  Google Scholar 

  • Zheng J, Thylin MR, Ghorpade A, Xiong H, Persidsky Y, Cotter R, Niemann D, Che M, Zeng YC, Gelbard HA, Shepard RB, Swartz JM, Gendelman HE (1999). Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1 associated dementia. J Neuroimmunol 98: 185–200.

    Article  CAS  PubMed  Google Scholar 

  • Zink MC, Amedee AM, Mankowski JL, Craig L, Didier P, Carter DL, Munoz A, Murphey-Corb M, Clements JE (1997). Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am J Pathol 151: 793–803.

    CAS  PubMed  Google Scholar 

  • Zink MC, Spelman JP, Robinson RB, Clements JE (1998). SIV infection of macaques—modeling the progression to AIDS dementia. J NeuroVirol 4: 249–259.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dianne M. Rausch.

Additional information

This article is not subject to U.S. copyright laws.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rausch, D.M., Davis, M.R. HIV in the CNS: Pathogenic relationships to systemic HIV disease and other CNS diseases. Journal of NeuroVirology 7, 85–96 (2001). https://doi.org/10.1080/13550280152058744

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1080/13550280152058744

Keywords

Navigation